Company news
Healios KK news in 2022
Healios KK's news releases, calls and decks from 2022, newest first.
TREASURE study results to be presented at the 14th World Stroke Congress
August 10, 2022
Exercise of Exclusive Option for a License Agreement with STEMAXON for the Development of UDC-Derived Photoreceptor Cells
July 12, 2022
Healios eNK Cells: Regenerative Medicine Product Quality Consultation with the PMDA for Planned Clinical Trials
July 12, 2022
Business Briefing for Institutional Investors
April 5, 2022
Progress Update in Relation to Application for Approval for HLCM051 for ARDS
April 4, 2022
Completion of 365 Days Post-Administration Follow Up for TREASURE Study for Patients with Ischemic Stroke
April 4, 2022
Joint Research with the Division of Regenerative Medicine, the Institute of Medical Science for Developing a Mass Production Method of UDC Liver Buds
April 1, 2022
License Agreement with CellFiber Co., Ltd.
March 24, 2022
Notice of the Partial Amendments to Articles of Incorporation
February 24, 2022
Notice of the Nomination of Candidates for the HEALIOS K.K. Board of Directors
February 24, 2022
Notice Concerning Reduction of Capital Stock and Capital Reserves and Appropriation of Surplus
February 24, 2022
Announcement of Change in Management
January 31, 2022